Drugs Made In America Acquisition II Corp. — Investor Relations & Filings
Drugs Made In America Acquisition II Corp. is a blank check company, also known as a special purpose acquisition company (SPAC). It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company intends to focus its search for a business combination target within the pharmaceutical industry.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Drugs Made In America Acquisition II Corp. (0002040475) (Filer) | 2026-04-28 | English | |
| 10-K - Drugs Made In America Acquisition II Corp. (0002040475) (Filer) | 2026-04-15 | English | |
| 8-K - Drugs Made In America Acquisition II Corp. (0002040475) (Filer) | 2026-04-03 | English | |
| QUARTERLY REPORT | 2025-11-18 | English | |
| CURRENT REPORT | 2025-11-17 | English | |
| NOTIFICATION OF LATE FILING | 2025-11-14 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
3 filings
| |||||
| 38191773 | 8-K - Drugs Made In America Acquisition II Corp. (0002040475) (Filer) | 2026-04-28 | English | ||
| 34607228 | 10-K - Drugs Made In America Acquisition II Corp. (0002040475) (Filer) | 2026-04-15 | English | ||
| 33302543 | 8-K - Drugs Made In America Acquisition II Corp. (0002040475) (Filer) | 2026-04-03 | English | ||
|
2025
12 filings
| |||||
| 13718380 | QUARTERLY REPORT | 2025-11-18 | English | ||
| 13718383 | CURRENT REPORT | 2025-11-17 | English | ||
| 13718381 | NOTIFICATION OF LATE FILING | 2025-11-14 | English | ||
| 13718382 | Director's Dealing 2025 | 2025-10-17 | English | ||
| 13718384 | CURRENT REPORT | 2025-10-02 | English | ||
| 13718385 | Director's Dealing 2025 | 2025-10-02 | English | ||
| 13718386 | Major Shareholding Notification 2025 | 2025-10-02 | English | ||
| 13718387 | Director's Dealing 2025 | 2025-10-01 | English | ||
| 13718388 | Director's Dealing 2025 | 2025-10-01 | English | ||
| 13718389 | Director's Dealing 2025 | 2025-10-01 | English | ||
| 13718390 | Director's Dealing 2025 | 2025-10-01 | English | ||
| 13718391 | CURRENT REPORT | 2025-09-29 | English | ||
Market data
Market data not available
Price history
Peer group · Activities of non-money market investments funds
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Abc Company
A business accelerator and consulting firm specializing in …
|
ABC | IT | Financial and insurance activit… |
|
AB Effectenbeteiligungen AG
Investment company acquiring equity stakes, primarily in sm…
|
ABE | AT | Financial and insurance activit… |
|
Aberdeen International Inc.
Global resource investment corporation and merchant bank sp…
|
AAB | CA | Financial and insurance activit… |
|
Aberforth Geared Value & Income Trust PLC
A fixed-life investment trust investing in a value portfoli…
|
AGVI | GB | Financial and insurance activit… |
|
Aberforth Smaller Companies Trust plc
An investment trust investing in a portfolio of small UK-qu…
|
ASL | GB | Financial and insurance activit… |
|
Aberforth Split Level Income Trust plc
A split capital trust investing in small UK companies with …
|
ASIT | GB | Financial and insurance activit… |
|
abrdn Asia Focus plc
Investment trust focused on smaller listed companies in Asi…
|
AAS | GB | Financial and insurance activit… |
|
abrdn Asian Income Fund Limited
Investment company targeting income and growth from high-yi…
|
AAIF | JE | Financial and insurance activit… |
|
ABRDN ASIA-PACIFIC INCOME FUND, INC.
A closed-end fund investing in Asia-Pacific debt securities…
|
FAX | US | Financial and insurance activit… |
|
abrdn Asia-Pacific Income Fund VCC
Closed-end fund investing in Asia-Pacific debt securities f…
|
FAP | SG | Financial and insurance activit… |
Drugs Made In America Acquisition II Corp. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35620/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35620 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35620 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35620 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35620}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Drugs Made In America Acquisition II Corp. (id: 35620)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.